阿齐思罗米的大规模药物管理:平衡儿童的生存益处和风险
Nubwa Medugu1, Ian C Michelow2, Claudette Poole3
1Department of Medical Microbiology and Immunology, Nile University of Nigeria, Abuja, Nigeria; International Foundation Against Infectious Diseases in Nigeria (IFAIN), Abuja, Nigeria.
The Lancet. Infectious diseases
|July 12, 2025
概括
大规模的阿齐思罗米药物管理表明,在低收入国家减少儿童死亡率是有前途的. 然而,其使用引发了对抗微生物药物耐药性的担忧,需要仔细考虑道德问题和强有力的监督.
科学领域:
- 全球健康 全球健康
- 传染性疾病 传染性疾病
- 公共卫生政策 公共卫生政策
背景情况:
- 在低收入和中等收入国家,特别是撒哈拉以南非洲,儿童死亡率仍然是一个重要的公共卫生问题.
- 大量药物管理 (MDA) 与阿齐思罗米已经显示出降低高风险地区五岁以下儿童死亡率的潜力.
- 亚齐思罗米辛MDA给予保护的精确机制及其更广泛的影响仍然不完全理解.
研究的目的:
- 分析目前关于阿齐思罗米辛MDA减少儿童死亡率的证据.
- 评估MDA对抗菌素耐药性 (AMR) 的潜在影响.
- 讨论伦理考虑,并提出未来的公共卫生干预优先事项.
主要方法:
- 关键随机对照试验 (RCT) 的审查,评估阿齐思罗米MDA.
- 分析影响阿齐思罗米辛MDA结果的因素,包括年龄,地理位置和并发症.
- 评估证据,将间歇性阿齐思罗米辛使用与宏类耐药性和生态影响联系起来.
主要成果:
- 阿兹罗米辛MDA结果是高度可变的,受参与者的人口统计学,地理位置,并发症,共感染和并发疗法的影响.
- 间歇性阿齐思罗米使用与病原体中宏类耐药性增加,对未经治疗的人群的潜在溢出效应和生态破坏有关.
- 诸如知情同意和资源分配等道德问题需要仔细考虑.
结论:
- 建议采用多方面的公共卫生方法,包括对水,环境卫生和卫生 (WASH) 的投资,疫苗接种计划和强有力的抗菌耐药性监测.
- 决策者和全球卫生利益相关者必须优先考虑特定于环境的,基于证据的战略.
- 加强当地能力,加强社区参与,实施严格的监测系统对于维持MDA的好处而不会损害公共健康至关重要.
更多相关视频
06:49Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
Published on: March 14, 2014
11.7K
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
13.0K
相关概念视频
01:21Factors Affecting Drug Response: Overview
2.4K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K
01:24Rational Dosage Regimen: Maintenance Dose and Loading Dose
4.4K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.4K
01:18Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
204
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
204
01:15Drug Dosage Regimen: Overview
3.8K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.8K
01:14Myocarditis III: Medical Management
17
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
17
01:19Pharmacovigilance
996
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
996